Go Deep
Instil Bio, Inc.
Instil Bio, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,884 | -1.4 | 0.38 | 0.81 | 564.94 |
| Oct 2026 | 21,837 | -1.4 | 0.39 | 0.81 | 582.11 |
| Oct 2026 | 21,807 | -1.3 | 0.37 | 0.81 | 559.77 |
| Oct 2026 | 21,639 | -1.3 | 0.37 | 0.81 | 548.99 |
| Oct 2026 | 21,597 | -1.3 | 0.38 | 0.81 | 563.21 |
| Oct 2026 | 21,630 | -1.3 | 0.36 | 0.81 | 545.74 |
| Oct 2026 | 21,650 | -1.3 | 0.36 | 0.81 | 538.03 |
| Oct 2026 | 21,610 | -1.3 | 0.37 | 0.81 | 553.53 |
Instil Bio, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -4,299,000.0 | -4,204,000.0 | -8,191,000.0 | -13,587,000.0 |
| EPS | -0.6 | -0.6 | — | -2.0 |
Instil Bio, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Profit | -71,372,000.0 | -74,135,000.0 | -156,087,000.0 | -223,177,000.0 | — |
| EPS | -10.7 | -11.4 | -24.0 | -34.4 | — |
Instil Bio, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 203,523,000.0 | 263,567,000.0 | 325,630,000.0 | 482,128,000.0 | — |
| Total Liabilities | 89,657,000.0 | 94,131,000.0 | 99,801,000.0 | 118,523,000.0 | — |
| Total Equity | 113,866,000.0 | 169,436,000.0 | 225,829,000.0 | 363,605,000.0 | — |
Owes vs Owns
Instil Bio, Inc. owed $0.46 for every $1 it owned in Jun 2026, up from $0.25 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.46× | 0.44× | 0.36× | 0.31× | 0.25× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Instil Bio, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 37.4%Other assets 62.0%
How it's funded — Dec 2025
Long-term debt 41.7%Other liabilities 1.8%Shareholders' equity 55.9%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 76.1 | 113.3 | 150.4 | 260.9 |
| Receivables | 0.8 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.4 | 130.3 | 141.1 | 209.3 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 23.2 | 0.0 |
| Other assets | 126.2 | 19.9 | 11.0 | 11.9 |
| Liabilities & equity | ||||
| Short-term debt | 0.4 | 1.7 | 1.8 | 2.4 |
| Long-term debt | 84.8 | 84.2 | 81.4 | 72.3 |
| Payables | 0.8 | 0.7 | 1.2 | 2.4 |
| Other liabilities | 3.7 | 7.6 | 15.4 | 41.4 |
| Shareholders' equity | 113.9 | 169.4 | 225.8 | 363.6 |
| Net tangible assets | 113.9 | 169.4 | 225.8 | 363.6 |
Instil Bio, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -36,619,000.0 | -55,696,000.0 | -82,029,000.0 | -180,164,000.0 | — |
| Investing Activities | 25,476,000.0 | 53,974,000.0 | 41,128,000.0 | 114,541,000.0 | — |
| Financing Activities | 7,292,000.0 | 1,755,000.0 | 8,082,000.0 | 71,886,000.0 | — |